This is evidenced by the ability of APE to alleviate glucose and insulin homeostasis, ameliorate metabolic derangement including dyslipidemia, hepatorenal dysfunction, and restore pancreatic oxidative stress and β‐cell function in the treated diabetic animals. This evidence concerns the gene INS and metabolic syndrome.